Literature DB >> 19794080

Large granular lymphocyte disorders: new etiopathogenetic clues as a rationale for innovative therapeutic approaches.

Renato Zambello, Gianpietro Semenzato.   

Abstract

Mesh：

Year:  2009        PMID： 19794080      PMCID： PMC2754948          DOI： 10.3324/haematol.2009.012161

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  47 in total

1.  Transformation of T-cell large granular lymphocyte leukaemia into a high-grade large T-cell lymphoma.

Authors:  E Matutes; A C Wotherspoon; N E Parker; N Osuji; P G Isaacson; D Catovsky
Journal:  Br J Haematol       Date:  2001-12       Impact factor: 6.998

2.  Chronic neutropenia mediated by fas ligand.

Authors:  J H Liu; S Wei; T Lamy; P K Epling-Burnette; G Starkebaum; J Y Djeu; T P Loughran
Journal:  Blood       Date:  2000-05-15       Impact factor: 22.113

3.  Neutropenia and anaemia associated with T-cell large granular lymphocyte leukaemia responds to fludarabine with minimal toxicity.

Authors:  Alexander Sternberg; Helen Eagleton; Nithiya Pillai; Kevin Leyden; Susan Turner; Danita Pearson; Timothy Littlewood; Chris Hatton
Journal:  Br J Haematol       Date:  2003-02       Impact factor: 6.998

4.  Dysregulated NK receptor expression in patients with lymphoproliferative disease of granular lymphocytes.

Authors:  Pearlie Kay Epling-Burnette; Jeffrey S Painter; Pratima Chaurasia; Fanqi Bai; Sheng Wei; Julie Y Djeu; Thomas P Loughran
Journal:  Blood       Date:  2004-01-15       Impact factor: 22.113

Review 5.  Survival signals in leukemic large granular lymphocytes.

Authors:  P K Epling-Burnette; Thomas P Loughran
Journal:  Semin Hematol       Date:  2003-07       Impact factor: 3.851

Review 6.  The role of CD95 in the regulation of peripheral T-cell apoptosis.

Authors:  Andreas Krueger; Stefanie C Fas; Sven Baumann; Peter H Krammer
Journal:  Immunol Rev       Date:  2003-06       Impact factor: 12.988

7.  Expression and function of KIR and natural cytotoxicity receptors in NK-type lymphoproliferative diseases of granular lymphocytes.

Authors:  Renato Zambello; Michela Falco; Mariella Della Chiesa; Livio Trentin; Davide Carollo; Roberta Castriconi; Giovanna Cannas; Simona Carlomagno; Anna Cabrelle; Thierry Lamy; Carlo Agostini; Alessandro Moretta; Gianpietro Semenzato; Massimo Vitale
Journal:  Blood       Date:  2003-05-15       Impact factor: 22.113

8.  Successful treatment of refractory pure red cell aplasia associated with lymphoproliferative disorders with the anti-CD52 monoclonal antibody alemtuzumab (Campath-1H).

Authors:  Xiuqing Ru; Howard A Liebman
Journal:  Br J Haematol       Date:  2003-10       Impact factor: 6.998

9.  Therapeutic implications of variable expression of CD52 on clonal cytotoxic T cells in CD8+ large granular lymphocyte leukemia.

Authors:  Sanjay R Mohan; Michael J Clemente; Manuel Afable; Heather N Cazzolli; Nelli Bejanyan; Marcin W Wlodarski; Alan E Lichtin; Jaroslaw P Maciejewski
Journal:  Haematologica       Date:  2009-10       Impact factor: 9.941

10.  2-deoxycoformycin in the treatment of T-large granular lymphocyte leukemia.

Authors:  Panagiotis Tsirigotis; Evangelos Venetis; Violeta Kapsimali; Dimitra Rontogianni; Ephrosini Varvitsioti; Vasiliki Pappa; Panos Apostolidis
Journal:  Leuk Res       Date:  2003-09       Impact factor: 3.156
View more
  16 in total

Review 1.  Natural killer cells in inflammatory heart disease.

Authors:  SuFey Ong; Noel R Rose; Daniela Čiháková
Journal:  Clin Immunol       Date:  2016-11-25       Impact factor: 3.969

Review 2.  Large granular lymphocytosis during dasatinib therapy.

Authors:  Zhi-Yuan Qiu; Wei Xu; Jian-Yong Li
Journal:  Cancer Biol Ther       Date:  2013-12-18       Impact factor: 4.742

3.  Oral cyclophosphamide was effective for Coombs-negative autoimmune hemolytic anemia in CD16+CD56- chronic lymphoproliferative disorder of NK-cells.

Authors:  Nodoka Sekiguchi; Sayaka Nishina; Toru Kawakami; Hitoshi Sakai; Noriko Senoo; Yasushi Senoo; Toshiro Ito; Hiroshi Saito; Hideyuki Nakazawa; Tomonobu Koizumi; Fumihiro Ishida
Journal:  Int J Hematol       Date:  2016-12-27       Impact factor: 2.490

4.  Multifactorial neutropenia in a patient with acute promyelocytic leukemia and associated large granular lymphocyte expansion: A case report.

Authors:  Gianluigi Reda; Bruno Fattizzo; Ramona Cassin; Elena Flospergher; Nicola Orofino; Umberto Gianelli; Wilma Barcellini; Agostino Cortelezzi
Journal:  Oncol Lett       Date:  2016-12-28       Impact factor: 2.967

Review 5.  All that glitters is not LGL Leukemia.

Authors:  Gianpietro Semenzato; Antonella Teramo; Giulia Calabretto; Vanessa Rebecca Gasparini; Renato Zambello
Journal:  Leukemia       Date:  2022-09-15       Impact factor: 12.883

6.  Defining TCRγδ lymphoproliferative disorders by combined immunophenotypic and molecular evaluation.

Authors:  Antonella Teramo; Andrea Binatti; Elena Ciabatti; Gianluca Schiavoni; Giulia Tarrini; Gregorio Barilà; Giulia Calabretto; Cristina Vicenzetto; Vanessa Rebecca Gasparini; Monica Facco; Iacopo Petrini; Roberto Grossi; Nadia Pisanti; Stefania Bortoluzzi; Brunangelo Falini; Enrico Tiacci; Sara Galimberti; Gianpietro Semenzato; Renato Zambello
Journal:  Nat Commun       Date:  2022-06-08       Impact factor: 17.694

7.  Detection of monoclonal T populations in patients with KIR-restricted chronic lymphoproliferative disorder of NK cells.

Authors:  Cristina Gattazzo; Antonella Teramo; Francesca Passeri; Elena De March; Samuela Carraro; Valentina Trimarco; Federica Frezzato; Tamara Berno; Gregorio Barilà; Veronica Martini; Francesco Piazza; Livio Trentin; Monica Facco; Gianpietro Semenzato; Renato Zambello
Journal:  Haematologica       Date:  2014-09-05       Impact factor: 9.941

Review 8.  Activating KIRs in Chronic Lymphoproliferative Disorder of NK Cells: Protection from Viruses and Disease Induction?

Authors:  Renato Zambello; Antonella Teramo; Gregorio Barilà; Cristina Gattazzo; Gianpietro Semenzato
Journal:  Front Immunol       Date:  2014-02-26       Impact factor: 7.561

9.  Are T-LGL Leukemia and NK-Chronic Lymphoproliferative Disorder really two distinct diseases?

Authors:  Renato Zambello; Antonella Teramo; Cristina Gattazzo; Gianpietro Semenzato
Journal:  Transl Med UniSa       Date:  2014-02-04

10.  Blood cell morphology and COVID-19 clinical course, severity, and outcome.

Authors:  Amirhossein Pezeshki; Atefeh Vaezi; Pardis Nematollahi
Journal:  J Hematop       Date:  2021-07-05       Impact factor: 0.196
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.